Akina Tamaki, MD
Otolaryngology-General, Otolaryngology-Head and Neck
Accepting New Patients
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland, OH 44106
- Assistant Professor, CWRU School of Medicine
Akina Tamaki, MD, is a board-eligible otolaryngologist and head and neck surgeon with fellowship training in head and neck oncology and microvascular reconstructive surgery. Her special interests include head and neck cancer and microvascular reconstruction. She also has interest in treating various other head and neck ailments, including thyroid and parathyroid disease, skin cancers, paraganglioma and salivary gland diseases. She is also certified in transoral robotic surgery.
Dr. Tamaki has published extensively in peer-reviewed journals and books. She is a reviewer in journals such as Oral Oncology. Her research interests include improving outcomes of complex head and neck reconstruction and improving the quality of care for head and neck cancer patients. She is also passionate about medical education and training future otolaryngologists. Dr. Tamaki joined the faculty in 2020.
She is a member of the American Academy of Otolaryngology – Head and Neck Surgery and the American Head and Neck Society.
Dr. Tamaki has a bachelor’s degree from Johns Hopkins University in Baltimore and earned her medical degree from University of Maryland in Baltimore. She completed her residency at University Hospitals Cleveland Medical Center. She then completed a fellowship in Head and Neck Oncology and Microvascular Reconstructive Surgery at The Ohio State University in Columbus.
- Head and Neck Cancer
- Head and Neck Reconstruction
- Head and Neck Trauma
- Salivary Gland Disease
- Skin Cancers
- Thyroid and Parathyroid Disease
- TransOral Robotic Surgery (TORS)
- Zenker’s Diverticulum
Fellowship | Head and Neck Oncology
Head and Neck Oncology - The Ohio State University Wexner Medical Center (2019 - 2020)
Residency | Otolaryngology
Otolaryngology - UH Cleveland Medical Center (2014 - 2019)
University Of Maryland School Of Medicine (2014)
Johns Hopkins University (2009)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Akina Tamaki did not disclose any Outside Relationships with Industry.